Side-by-side comparison of AI visibility scores, market position, and capabilities
Vessel provides unified CRM and sales tool APIs enabling B2B SaaS products to natively integrate with Salesforce, HubSpot, and other go-to-market platforms.
Vessel is a developer tools company founded in 2022 that provides unified APIs for CRM and sales technology integrations, allowing B2B SaaS products to connect with customers' Salesforce, HubSpot, Pipedrive, and other GTM tools through a single normalized API. The company targets revenue intelligence, sales engagement, and analytics tools whose primary value depends on seamless data access to and from customer CRM systems. Building and maintaining native CRM integrations is notoriously complex given the depth of Salesforce and HubSpot's data models, authentication complexity, and rate limiting requirements. Vessel abstracts these complexities into a unified data model and connection management platform that reduces integration development time from months to days. The company raised $5M and serves B2B SaaS companies whose products are embedded in the sales and marketing tech stack. Vessel handles OAuth connection management, data normalization across CRM schemas, webhook forwarding, and write-back operations, providing a complete bidirectional integration layer. The platform is particularly valuable for startups in the GTM tech space that need CRM integrations to close enterprise deals but lack the engineering capacity to build and maintain them in-house.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.